Cadila Healthcare is currently trading at Rs. 1573.00, up by 4.35 points or 0.28 % from its previous closing of Rs. 1568.65 on the BSE.
The scrip opened at Rs. 1560.00 and has touched a high and low of Rs. 1583.00 and Rs. 1556.50 respectively. So far 1416 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1760.00 on 11-Nov-2014 and a 52 week low of Rs. 730.25 on 06-Jan-2014.
Last one week high and low of the scrip stood at Rs. 1617.90 and Rs. 1520.45 respectively. The current market cap of the company is Rs. 32237.65 crore.
The promoters holding in the company stood at 74.79 % while Institutions and Non-Institutions held 14.51 % and 10.69 % respectively.
Cadila Healthcare is developing vaccines for ‘Congo Virus’ and ‘Ebola Virus’ as a part of Company's vaccine development programme. However, the company has not shared investment details.
Cadila Healthcare operates in areas of active pharmaceutical ingredients (API) to formulations, and animal health products to cosmeceuticals.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1505.20 |
Dr. Reddys Lab | 5922.45 |
Cipla | 1339.45 |
Zydus Lifesciences | 983.05 |
Lupin | 1609.85 |
View more.. |